|
1. Iñiguez, M.A., Punzón, C. and Fresno, M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J. Immunol 163:111-119 (1999)
2. Iñiguez, M.A., Martínez-Martínez, S., Punzón, C., Redondo, J.M. and Fresno, M. An essential role of nuclear factor of activated T cells in the regulation of the expression of cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275, 23627-23633 (2000).
3. Hernández, G.L., Volpert,O.V., Íñiguez, M.A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M. and Redondo J.M. Selective inhibition of Vascular Endothelial Growth Factor–mediated Angiogenesis by Cyclosporin A: Roles of the Nuclear Factor of Activated T Cells and Cyclooxygenase 2. J. Exp. Med. 193, 607-620 (2001)
4. Lara-Pezzi, E., Gómez-Gaviro, Mª V., Gálvez, B.G., Mira, E., Iniguez, M.A., Fresno, M., Martínez-A, C., Arroyo, A.G. and López-Cabrera, M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110, 1831-1838 (2002).
5. Grau, R., Iñiguez, M.A. and Fresno, M. Inhibition of activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferators-activated receptor--independent mechanism. Cancer Res. 64, 5162-5171 (2004).
|
